ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "autoimmune diseases"

  • Abstract Number: 1937 • 2015 ACR/ARHP Annual Meeting

    Dalazatide (ShK-186), a First-in-Class Blocker of Kv1.3 Potassium Channel on Effector Memory T Cells: Safety, Tolerability and Proof of Concept of Immunomodulation in Patients with Active Plaque Psoriasis

    Ernesto J. Munoz-Elias1, David Peckham1, Kayla Norton1, Judilyn Duculan2, Inna Cueto2, Xuan Li3, James Qin4, Kurt Lustig5, Eric Tarcha1, Jared Odegard4, James G. Krueger2 and Shawn P. Iadonato1, 1Kineta Inc, Seattle, WA, 2Rockefeller University, New York, NY, 3Rockefeller University, New York, WA, 4Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Kineta Inc., Seattle, WA

    Background/Purpose: Effector memory T cells of both CD4 and CD8 lineages are key drivers of autoimmunity and are pathogenic in several autoimmune diseases including psoriasis,…
  • Abstract Number: 1947 • 2015 ACR/ARHP Annual Meeting

    Hypermethylation of Treg-Specific Demethylated Regions in the Ikaros Transcription Factor Family Members, Helios and Eos, in Rheumatoid Arthritis Tregs

    Alla Skapenko1, Viktoria Soentgerath1, Sonja Haupt2, Jan Leipe1 and Hendrik Schulze-Koops1, 1Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, 2Division of Rheumatology and Clinical Immunology, Med.Klinik und Poliklinik IV, University of Munich, Munich, Germany

    Background/Purpose: Foxp3 is the signature transcription factor of regulatory T cells (Tregs) and facilitates many of the characteristic functions of Tregs. Members of the Ikaros…
  • Abstract Number: 2101 • 2015 ACR/ARHP Annual Meeting

    HLA Associations in Mothers of Children with Cardiac Manifestations of Neonatal Lupus

    Hannah C. Ainsworth1, Carl D. Langefeld1, Miranda C. Marion2, Nathalie Costedoat-Chalumeau3, Antonio Brucato4, Jill P. Buyon5 and Robert M. Clancy5, 1Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 2Biostatistical Sciences and Center for Public Health Genomics, Wake Forest University Health Sciences, Winston-Salem, NC, 3Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 4Internal Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy, 5Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

    Background/Purpose: Cardiac manifestations of neonatal lupus, comprising atrioventricular conduction defects and cardiomyopathy, occur in fetuses exposed to anti-Ro/SSA antibodies, and carry substantial mortality. There is…
  • Abstract Number: 233 • 2014 ACR/ARHP Annual Meeting

    Significance of Serum Marker Levels of Wnt/ß-Catenin Signaling Pathway in Patients with Systemic Autoimmune Diseases Under Glucocorticoid Therapy; A Prospective Study

    Mai Kawazoe, Kotaro Shikano, Kaichi Kaneko, Shotaro Masuoka, Hiroshi Sato, Emiko Shindo, Natsuki Fujio, Sei Muraoka, Makoto Kaburaki, Nahoko Tanaka, Tatsuhiro Yamamoto, Kenji Takagi, Natsuko Kusunoki, Tomoko Hasunuma and Shinichi Kawai, Division of Rheumatology, Department of Internal Medicine, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan

    Background/Purpose:  Glucocorticoids are widely used to treat a variety of diseases, including systemic autoimmune diseases. Although glucocorticoids improve the outcome for patients with these diseases,…
  • Abstract Number: L4 • 2014 ACR/ARHP Annual Meeting

    Safety and Efficacy of Sifalimumab, an Anti IFN-Alpha Monoclonal Antibody, in a Phase 2b Study of Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Munther Khamashta1,2, Joan T. Merrill3, Victoria P. Werth4,5, Richard Furie6, Kenneth Kalunian7, Gabor G. Illei8, Jorn Drappa8, Liangwei Wang8 and Warren Greth8, 1Division of Women's Health, Graham Hughes Lupus Research Laboratory, King's College London, London, United Kingdom, 2Lambeth Wing, The Rayne Institute, St Thomas' Hospital London, London, United Kingdom, 3Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Philadelphia VA Medical Center, Philadelphia, PA, 5University of Pennsylvania, Philadelphia, PA, 6North Shore-LIJ Health System, Lake Success, NY, 7UCSD School of Medicine, La Jolla, CA, 8MedImmune, LLC, Gaithersburg, MD

    Background/Purpose: Efficacy and safety of sifalimumab were assessed in a Phase 2b, randomized, double-blind, placebo (PBO)-controlled study in subjects with SLE (NCT01283139). Methods: Adults (n=431)…
  • Abstract Number: 2956 • 2014 ACR/ARHP Annual Meeting

    Identification of Autoimmune Functional Variants Under Positive Selection in the Gullah African American Population of South Carolina

    Paula S. Ramos1, Satria Sajuthi2, Jasmin Divers2, Yiqi Huang3, Uma Nayak4, Wei-Min Chen4, Kelly J. Hunt5, Diane L. Kamen6, Gary S. Gilkeson6, Jyotika K. Fernandes7, Ida J. Spruill7, W. Timothy Garvey8, Michèle M. Sale3 and Carl D. Langefeld2, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Medicine and Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 4Public Health Sciences, University of Virginia, Charlottesville, VA, 5Public Health Sciences, Medical University of South Carolina, Charleston, SC, 6Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 7Medical University of South Carolina, Charleston, SC, 8Department of Nutrition Sciences and Birmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose The reasons for the ethnic disparities in rheumatologic and autoimmune diseases (ADs) are largely unknown. We posit that population-specific selection influencing the allele frequencies…
  • Abstract Number: 2848 • 2014 ACR/ARHP Annual Meeting

    T-Cell Signaling Defects Can be Corrected By Manipulating ‘TCR Signal Fine-Tuning Molecules’ That Are Altered Due to Increased Ubiquitination in Systemic Autoimmune Disease

    Julia Pinkhasov1 and Ram Raj Singh1,2,3,4, 1Autoimmunity and Tolerance Laboratory, Department of Medicine/Rheumatology, UCLA, Los Angeles, CA, 2Interdepartmental Program in Molecular Toxicology, UCLA, Los Angeles, CA, 3Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, 4Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA

    Background/Purpose . T-cell selection in the thymus is primarily determined by the avidity of T cell receptor (TCR) for self-ligand-MHC. Since this process is dependent…
  • Abstract Number: 2779 • 2014 ACR/ARHP Annual Meeting

    Systemic Inflammatory and Autoimmune Manifestations Associated with Myelodysplastic Syndrome: A French Multicenter Retrospective Study

    Arsene Mekinian1, Eric Grignano1, Thorsten Braun2, Olivier Decaux3, Eric Liozon4, Nathalie Costedoat-Chalumeau5, Jean Emmanuel Kahn6, Mohamed Hamidou7, Geraldine Falgarone8, Olivier Lortholary9, Sophie Park10, Zahir Amoura11, A. Mathian12, Bruno Gombert13, Christian Rose14, Xavier Puechal15, David Launay16, Guillaume Denis17, Bertrand Lioger18, Anne Laure Buchdaul19, Sophie georgin Lavialle20, Francois Montestruc21, Mohammed Omouri22, Julien Rossignol23, Jean Marc Ziza24, Pascal Cathebras25, Serge Madaule26, Benoit de Wazières27, Nathalie Morel15, Sebastien Trouillet28, Loic Raffray29, Yoland Schoindre30, Eric Toussirot31, jean Charles Piette32, Claude Gardin2, Lionel Ades33, Pierre Fenaux33 and Olivier Fain34, 1Internal Medicine, DHUi2B Saint Antoine Hospital, paris, France, 2Haematology department Avicenne Hospital, bobigny, France, 3Department of Internal Medicine, Rennes University Hospital, Rennes, France, 4INTERNAL MEDICINE, DIJON, France, 5Internal Medicine, Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 6Internal medicine Hopital Foch, PARIS, France, 7CHU Hôtel Dieu, Nantes, Nantes, France, 8Rheumatology department Avicenne Hospital INSERM 1125, bobigny, France, 9Service de maladies infectieuses, Hôpital Necker-Enfants malades, AP-HP, Paris, France, 10Haematology Department, Grenoble University Hospital, grenoble, France, 11Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 12Internal Medecine Department, Pitie-Salpetriere Hospital, Paris, France, 13Internal Medicine, La Rochelle hospital, La Rochelle, France, 14haematology, lille, France, 15Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 16Service de médecine interne, Centre National de Référence de la Sclérodermie Systémique, Hôpital Claude Huriez, CHRU Lille, Lille, France, 17Internal Medicine, Rochefoucault hospital, Rochefoucault, France, 18INTERNAL MEDICINE, tours, France, 19Internal Medicine, Douai hospital, Douai, France, 20Internal Medicine Department Tenon Hospital, paris, France, 21exystat, PARis, France, 22Rheumatology Department Romilly Hospital, romilly, France, 23haematology, paris, France, 24Hopital Croix-Saint-Simon, Paris Cedex 20, France, 25Internal Medicine, University Hospital St Etienne, St Etienne, France, 26Medecine interne, Chg, Albi, France, 27Department of Internal Medicine and Gerontology, Hôpital Universitaire Carémeau, Nîmes, France, Nimes, France, 28INTERNAL MEDICINE, aurillac, France, 29INTERNAL MEDICINE, bordeaux, France, 30DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, PARIS, France, 31Clinical Investigation Centre Biotheraoy CIC 1431, Rheumatology Department, Univesity Hospital, besancon, France, 32INTERNAL MEDICINE, PARIS, France, 33Haematology department Saint Louis Hospital, paris, France, 34Hôpital Saint Antoine, DHU i2B, Service de Médecine Interne, paris, France

    Background/Purpose: To describe characteristics, treatment and outcome of patients with systemic inflammatory or autoimmune diseases (SAID) and myelodysplastic syndrome (MDS).Methods: For this retrospective study, a…
  • Abstract Number: 2359 • 2014 ACR/ARHP Annual Meeting

    CGEN-15001, a Novel Immunomodulatory Fusion Protein of the B7 Family Induces Immune Tolerance and Shows Efficacy in Mouse Models of Rheumatoid Arthritis and Psoriasis

    Iris Hecht1, Kay McNamee2, Aviad Keren3, Joseph R. Podojil4, Ilan Vaknin1, Anat Oren1, Galit Rotman1, Eyal Neria1, Stephen D. Miller4, Amos Gilhar3 and Richard O. Williams2, 1Compugen Ltd., Tel Aviv, Israel, 2Kennedy Institute of Rheumatology, Oxford University, Oxford, United Kingdom, 3Technion Institute of Technology, Haifa, Israel, 4Microbiology-Immunology, Northwestern University, Chicago, IL

    Background/Purpose CGEN-15001 is an Fc-fusion protein consisting of the extracellular domain of a novel B7-like protein, discovered based on shared family characteristics. CGEN-15001 inhibits T…
  • Abstract Number: 2201 • 2014 ACR/ARHP Annual Meeting

    Haematological Complications in Rheumatic Diseases: Not Only Lymphomas

    Elena Elefante1, Chiara Baldini1, Alice Parma1, Elisa Cioffi2, Francesco Ferro1, Roberta Vagelli2, Martina Rousseau3, Rosaria Talarico2, Sara Galimberti3 and Stefano Bombardieri2, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2Rheumatology Unit, Pisa, Italy, 3Hematology Unit, Pisa, Italy

    Background/Purpose Several immunological abnormalities have been reported among patients affected by myelodisplastic syndrome (MDS). On the other hand, a relatively limited number of studies have…
  • Abstract Number: 2190 • 2014 ACR/ARHP Annual Meeting

    Features of Interstitial Lung Disease Associated with Connective Tissue Disease in a Spanish Southwest Cohort

    Adela Gallego Flores1, Carmen Carrasco Cubero2, Raul Veroz Gonzalez1, Luz Maria Mellado Narciso1, Tamara Libertad Rodriguez Araya1, Juan Jose Aznar Sánchez1 and Eugenio Chamizo Carmona1, 1Rheumatology, Hospital de Mérida, Mérida, Spain, 2Rheumatology, Hospital de Merida, Mérida, Spain

    Background/Purpose Diffuse interstitial lung disease (ILD) can be associated with connective tissue diseases (CTD), and can increase morbidity and mortality significantly. The predominant patterns of…
  • Abstract Number: 2182 • 2014 ACR/ARHP Annual Meeting

    Investigating the Roles of Factor H-Related Proteins in Systemic Lupus Erythematosus (SLE) and Other Autoimmune Diseases

    Alexandra Antonioli1, Brandon Renner2, Joshua Thurman3, V. Michael Holers4 and Jonathan Hannan4, 1Department of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO, 3Renal Division, University of Colorado School of Medicine, Aurora, CO, 4Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose Complement plays a central role in the pathogenesis of systemic lupus erythematosus (SLE) wherein inappropriate activation of complement leads to substantial tissue damage, especially…
  • Abstract Number: 2167 • 2014 ACR/ARHP Annual Meeting

    Snapin Is Critical for Cathepsin D Activation and the Normal Lysosomal Function

    Bo Shi1, Qi Quan Huang2, Robert Birkett2, Renee E. Koessler1, Andrea Dorfleutner1, Christian Stehlik1 and Richard M. Pope1, 1Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose:  Our recent data indicates that Snapin, a SNAP associated protein, is critical for maintaining healthy autophagy and monocytes to macrophage (MFs) differentiation which requires…
  • Abstract Number: 1359 • 2014 ACR/ARHP Annual Meeting

    Care of Women with Rheumatological Conditions during Family Planning and Pregnancy

    Megan E. B. Clowse1, Munther Khamashta2, Daphnee S. Pushparajah3 and Eliza Chakravarty4, 1Rheumatology, Duke University Medical Center, Durham, NC, 2Graham Hughes Lupus Research Laboratory, The Rayne Institute, London, United Kingdom, 3UCB Pharma, Brussels, Belgium, 4OMRF, Oklahoma City, OK

     Background/Purpose Rheumatological diseases often affect women of reproductive age and can impact pregnancy outcomes. There is a need to understand how patients (pts) are managed…
  • Abstract Number: 1073 • 2014 ACR/ARHP Annual Meeting

    Prescription Medication Trends in Medicaid-Enrolled Pregnant Women with Rheumatoid Arthritis, Psoriasis, and Systemic Lupus Erythematosus

    Rishi Desai1, Krista Huybrechts2, Brian Bateman2, Helen Mogun2, Sonia Hernandez-diaz3 and Seoyoung C. Kim4, 1PharmacoEpidemiology & PharmacoEconomics, Brigham and Women's Hospital, Boston, MA, 2Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, MA, 3Harvard School of Public Health, Boston, MA, 4Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose:   Little is known about the trends of medication use in pregnant women with autoimmune disorders. The objective of the current study was to…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology